Hervé Eloi Dominique Brailly
Algemeen Directeur bij INNATE PHARMA
Vermogen: 2 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Hervé Eloi Dominique Brailly
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 52 | |
17
| Private Company | Biotechnology | 17 |
École Nationale Supérieure des Mines de Paris
12
| College/University | Other Consumer Services | 12 |
| Holding Company | Pharmaceuticals: Major | 12 | |
EuroBioMed
 EuroBioMed Miscellaneous Commercial ServicesCommercial Services EuroBioMed engages as an association related to healthcare research, engineering innovation and support for companies and projects. It operates in the following business segments: teaching, fundamental, translational and clinical research, technological innovation centers, start-ups and, industrial success stories. The company was founded in 2009 and is headquartered in Marseille, France.
3
| Private Company | Miscellaneous Commercial Services | 3 |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
2
| Non-Profit Organization | Miscellaneous Commercial Services | 2 |
Université d'Aix-Marseille
2
| College/University | Other Consumer Services | 2 |
Kalsiom SAS
 Kalsiom SAS Pharmaceuticals: MajorHealth Technology Kalsiom SAS develops inflammatory auto-immunity disorders antibody therapy. The company was founded by Hervé Eloi Dominique Brailly and Olivier Mignen on April 20, 2020 and is headquartered in Brest, France.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Chambre de Commerce et d'Industrie Marseille Provence
 Chambre de Commerce et d'Industrie Marseille Provence Other TransportationTransportation Chambre de Commerce et d'' Industrie Marseille Provence engages in the provision of financial information and trainings for business development. The company was founded on March 1, 1983 and is headquartered in Marseille, France.
1
| Private Company | Other Transportation | 1 |
BioCuster
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hervé Eloi Dominique Brailly via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Lyon | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| ESSEC Business School | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| THERADIAG | Medical Specialties | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| SANOFI | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| ABIVAX | Pharmaceuticals: Other | Founder General Counsel Director/Board Member | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Founder Private Equity Investor | |
| GENEURO SA | Biotechnology | Director/Board Member Director/Board Member | |
Jalon Therapeutics
 Jalon Therapeutics Pharmaceuticals: MajorHealth Technology Jalon Therapeutics is a French company that aims to develop innovative therapies to treat cancer by inactivating vital tumor signaling pathways. Jalon Therapeutics is based in Paris, France and manages an extensive candidate portfolio of drug candidates infused by its unique expertise in AAC-11 biology. The company leverages their deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. The company's lead candidate, JRT39, is the first-in-class drug developed for the treatment of hard-to-treat cancers. The company is building a drug discovery platform to develop other candidates derived from AAC-11 and AAC-11 partners for the treatment of cancer. Jalon Therapeutics raised a pre-seed in 2022, leveraged by non-dilutive and quasi-equity fundings from public institutions. The company's growth ambition is to raise a seed immediately followed by a series A to finance up to the clinical proof of concept of their lead candidate JRT39. The company was founded in 2021 by Jérôme Tiollier, Jean-Luc Poyet, Prof. Martine Bagot, Prof. Hervé Dombret, Jean-Christophe Rain, and Philippe Salphati. The CEO is David Loison. | Pharmaceuticals: Major | Director/Board Member Founder | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Director/Board Member | |
Mckinsey & Co. SAS
 Mckinsey & Co. SAS Miscellaneous Commercial ServicesCommercial Services Mckinsey & Co. SAS provides business and management consulting services. The company is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| QIAGEN MARSEILLE | Miscellaneous Commercial Services | Founder Director of Finance/CFO | |
Lafarge Canada, Inc.
 Lafarge Canada, Inc. Construction MaterialsNon-Energy Minerals Lafarge Canada, Inc. engages in the provision of construction materials. It offers aggregates, asphalt, cement, concrete products, and ductal. The company was founded in 1956 and is headquartered in Calgary, Canada. | Construction Materials | Corporate Officer/Principal President | |
| Artedrone SAS | Director/Board Member Director/Board Member | ||
| AMGEN INC. | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree | |
| Harvard Business School | College/University | Undergraduate Degree Graduate Degree | |
| EM Lyon Business School | College/University | Undergraduate Degree Masters Business Admin | |
| AFFLUENT MEDICAL | Medical Specialties | Founder Chief Executive Officer | |
| LAFARGE | Construction Materials | Corporate Officer/Principal Corporate Officer/Principal | |
| MICHELIN (CGDE) | Automotive Aftermarket | Corporate Officer/Principal Corporate Officer/Principal | |
| NNIT A/S | Information Technology Services | Director/Board Member Corporate Officer/Principal | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Miscellaneous Commercial Services | Chairman Director of Finance/CFO | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 36 |
| Verenigde Staten | 7 |
| Denemarken | 4 |
| Verenigd Koninkrijk | 3 |
| België | 2 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 5 |
| Non-Energy Minerals | 3 |
Operationeel
| Director/Board Member | 547 |
| Corporate Officer/Principal | 202 |
| Chairman | 160 |
| Chief Executive Officer | 97 |
| Independent Dir/Board Member | 84 |
Sterkste connecties
| Insiders | |
|---|---|
| Anne-Sophie Herelle | 65 |
| Patrick Sayer | 55 |
| Philippe Pouletty | 51 |
| Laurence Danon-Arnaud | 37 |
| Célia Hart | 36 |
| Jean-Daniel Henri Beurnier | 34 |
| Charles Woler | 29 |
| Catherine Moukheibir | 29 |
| Tidjane Thiam | 28 |
| Philippe Boucheron | 24 |
| Olivier Andriès | 24 |
| Stéphane Boissel | 24 |
| Philippe Archinard | 24 |
| Jean Deleage | 23 |
| Patrick J. Langlois | 23 |
- Beurs
- Insiders
- Hervé Eloi Dominique Brailly
- Bedrijfsconnecties
